Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.530
+0.020 (1.32%)
At close: Oct 9, 2025, 4:00 PM EDT
1.530
0.00 (-0.01%)
After-hours: Oct 9, 2025, 4:12 PM EDT
PACB Market Cap
PACB has a market cap or net worth of $459.57 million as of October 9, 2025. Its market cap has decreased by -3.09% in one year.
Market Cap
459.57M
Enterprise Value
838.04M
1-Year Change
-3.09%
Ranking
Category
Stock Price
$1.53
Market Cap Chart
Since October 27, 2010, PACB's market cap has decreased from $823.90M to $459.57M, a decrease of -44.22%. That is a compound annual growth rate of -3.83%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 8, 2025 | 453.60M | -9.50% |
Dec 31, 2024 | 501.20M | -80.90% |
Dec 29, 2023 | 2.62B | 41.85% |
Dec 30, 2022 | 1.85B | -59.02% |
Dec 31, 2021 | 4.51B | -3.45% |
Dec 31, 2020 | 4.67B | 494.29% |
Dec 31, 2019 | 786.60M | -28.61% |
Dec 31, 2018 | 1.10B | 259.04% |
Dec 29, 2017 | 306.90M | -12.84% |
Dec 30, 2016 | 352.10M | -65.19% |
Dec 31, 2015 | 1.01B | 80.82% |
Dec 31, 2014 | 559.40M | 61.68% |
Dec 31, 2013 | 346.00M | 262.30% |
Dec 31, 2012 | 95.50M | -37.79% |
Dec 30, 2011 | 153.50M | -81.73% |
Dec 31, 2010 | 840.40M | 2.00% |
Oct 27, 2010 | 823.90M | - |
View and export this data all the way back to 2010. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 758.63B |
Johnson & Johnson | 453.15B |
AbbVie | 406.64B |
UnitedHealth Group | 324.93B |
Novo Nordisk | 269.41B |
AstraZeneca | 265.89B |
Novartis AG | 257.47B |
Abbott Laboratories | 232.77B |